Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aurinia Pharm Ord (AUPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 539,668
  • Shares Outstanding, K 83,540
  • Annual Sales, $ 170 K
  • Annual Income, $ -23,300 K
  • 36-Month Beta 2.56
  • Price/Sales 3,143.43
  • Price/Cash Flow 0.00
  • Price/Book 3.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.10 +0.82%
on 10/20/17
7.60 -19.08%
on 10/13/17
-0.26 (-4.06%)
since 09/20/17
3-Month
5.66 +8.66%
on 08/10/17
7.60 -19.08%
on 10/13/17
-0.45 (-6.82%)
since 07/20/17
52-Week
2.02 +204.46%
on 12/22/16
10.54 -41.65%
on 03/13/17
+2.32 (+60.57%)
since 10/20/16

Most Recent Stories

More News
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome

--R&D Day Featuring KOLs in Nephrology and Ophthalmology Will be Webcast Today at 8:30a.m. ET in New York

AUP.TO : 7.77 (-3.72%)
AUPH : 6.15 (-4.80%)
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Aurinia Pharmaceuticals (AUPH) needs Investors to pay close attention to the stock based on moves in the options market lately.

AUPH : 6.15 (-4.80%)
Aurinia Pharmaceuticals (AUPH) Looks Good: Stock Adds 7.8% in Session

Aurinia Pharmaceuticals saw its shares rise nearly 8% on the day.

AUPH : 6.15 (-4.80%)
MEIP : 2.68 (+2.29%)
Today's Research Reports on Stocks to Watch: Inotek Pharmaceuticals and Aurinia Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Inotek shares saw red on Friday but it was an encouraging day last Thursday when the company announced the preliminary proxy statement for its proposed merger...

AUPH : 6.15 (-4.80%)
ITEK : 2.38 (+2.15%)
Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?

Investors certainly have to be happy with Aurinia Pharmaceuticals Inc (AUPH) and its short term performance

AUPH : 6.15 (-4.80%)
Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today announced it has received this year's National Corporate Visionary Award from the Lupus Foundation of America. The award was...

AUP.TO : 7.77 (-3.72%)
AUPH : 6.15 (-4.80%)
Research Initiated on Healthcare Stocks, Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / October 3, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select...

AUP.TO : 7.77 (-3.72%)
IPCI.TO : 1.25 (-0.79%)
IMV.TO : 1.36 (+7.09%)
AUPH : 6.15 (-4.80%)
ONC.TO : 0.57 (-1.72%)
IPCI : 1.00 (unch)
Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma

If you want a Stock Review on FOLD, ARGS, ARRY, or AUPH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today, DailyStockTracker.com shifts focus on...

FOLD : 13.59 (-5.03%)
AUPH : 6.15 (-4.80%)
ARGS : 0.17 (unch)
ARRY : 11.08 (-2.29%)
Aurinia to Host R&D Day and Webcast on October 20th in New York, NY

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today announced that it will host an R&D Day on October 20, 2017 at 8:00am Eastern Time in New York, NY. Members of the Aurinia leadership...

AUP.TO : 7.77 (-3.72%)
AUPH : 6.15 (-4.80%)
Aurinia to Webcast at Upcoming Investor Conferences

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) ("Aurinia" or the "Company") plans to present at three upcoming investor conferences where Aurinia management will provide an overview...

AUP.TO : 7.77 (-3.72%)
AUPH : 6.15 (-4.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Support & Resistance

2nd Resistance Point 6.94
1st Resistance Point 6.55
Last Price 6.15
1st Support Level 5.93
2nd Support Level 5.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart